China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
Nikkei Asia Business·14h·Media
ChannelsstocksCountriesjapan, asia, chinaCategoriesmergers-acquisitions
Open original source ↗Published
5/29/2026, 3:07:12 AM
Fetched
5/29/2026, 3:07:12 AM
Confidence
60 / 100
Relevance
42 / 100
Trust
media · 60/100
Language
en